Welcome to MIDHOS

Initially coined MIDHAS: Metabolism I Inflammation I Digital Health to Advance Systems Medicine, the consortium changed its name to MIDHOS: Metabolism I Inflammation I Digital Health I OSteology to also reflect the broad expertise in musculoskeletal health in its title. MIHOS is a collaborative consortium of researchers dedicated to advancing interdisciplinary science across musculoskeletal health, metabolic disease, inflammation, digital health, and related fields. Our members' expertise fundamental discovery, clinical research, and data-driven methodologies to drive innovation and tackle the complexities of chronic disease to support healthy aging.

Under the umbrella of MIDHOS we are hosting two flagship initiatives:

MeHDI Logo
ORN Logo

MeHDI - Metabolic Health, Digitization & Inflammation - is a research cluster dedicated to collaborative research in metabolic and inflammatory disorders, advanced imaging, digital biomarkers, and computational modeling. By leveraging multi-modal data from molecular and cellular biology, patient cohorts, medical imaging, and digital health tools, MeHDI aims to contribute to a holistic vision of health: shifting medicine from reactive to predictive, and enabling therapies tailored to individual physiology and disease trajectories.

The Osteology Research Network (ORN) is MeHDI's companion initiative, dedicated to bone- and musculoskeletal-related research, bone metabolism, and structural health. In concert with MeHDI, ORN ensures that skeletal health and bone integrity remain a central pillar of the overarching systems-medicine strategy.

Although distinct initiatives, MeHDI & ORN overlap strongly in methodology, data integration, and overarching goals. Together under MIDHOS, they provide a balanced, comprehensive framework for understanding human health across tissues, systems, and scales.

MeHDI & ORN researchers - driven by a systems-based approach - have a common vision to make personalized, predictive, and proactive health management a reality for everyone.